Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score-matched analysis.

Takamori S, Tagawa T, Toyokawa G, Ueo H, Shimokawa M, Kinoshita F, Matsubara T, Kozuma Y, Haratake N, Akamine T, Katsura M, Takada K, Hirai F, Shoji F, Okamoto T, Oda Y, Maehara Y.

Cancer Med. 2018 May 29. doi: 10.1002/cam4.1539. [Epub ahead of print]

2.

The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer.

Inoue Y, Yamashita N, Ueo H, Tanaka K, Saeki H, Oki E, Tokunaga E, Maehara Y.

Anticancer Res. 2018 Apr;38(4):2359-2362.

PMID:
29599361
3.

Erratum to immediate breast volume replacement using a free dermal fat graft after breast cancer surgery: multi-institutional joint research of short-term outcomes in 262 Japanese patients.

Kijima Y, Koriyama C, Fujii T, Hirokaga K, Ishigure K, Kaneko T, Kayano S, Miyamoto S, Sagara Y, Sakurai T, Sakurai T, Sotome K, Ueo H, Wakita K, Watatani M.

Gland Surg. 2017 Dec;6(6):756-757. doi: 10.21037/gs.2017.12.03.

4.

Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer.

Ito S, Kai Y, Masuda T, Tanaka F, Matsumoto T, Kamohara Y, Hayakawa H, Ueo H, Iwaguro H, Hedrick MH, Mimori K, Mori M.

Surg Today. 2017 Dec;47(12):1500-1511. doi: 10.1007/s00595-017-1544-4. Epub 2017 May 29.

PMID:
28555267
5.

A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.

Inoue Y, Yamashita N, Tokunaga E, Tanaka K, Ueo H, Saeki H, Oki E, Yamamoto H, Maehara Y.

Anticancer Res. 2017 Apr;37(4):1917-1921.

PMID:
28373460
6.

Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green.

Shinden Y, Ueo H, Tobo T, Gamachi A, Utou M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.

Sci Rep. 2016 Jun 9;6:27525. doi: 10.1038/srep27525.

7.

An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.

Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori K.

PLoS One. 2015 Oct 14;10(10):e0139808. doi: 10.1371/journal.pone.0139808. eCollection 2015.

8.

miR-29b is an indicator of prognosis in breast cancer patients.

Shinden Y, Iguchi T, Akiyoshi S, Ueo H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Eguchi H, Sugimachi K, Kijima Y, Natsugoe S, Mimori K.

Mol Clin Oncol. 2015 Jul;3(4):919-923. Epub 2015 May 12.

9.

Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green.

Ueo H, Shinden Y, Tobo T, Gamachi A, Udo M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.

Sci Rep. 2015 Jul 13;5:12080. doi: 10.1038/srep12080.

10.

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.

Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, Doki Y, Mori M, Ochiya T, Mimori K.

Br J Cancer. 2015 Jul 14;113(2):275-81. doi: 10.1038/bjc.2015.201. Epub 2015 Jun 9.

11.

Immediate breast volume replacement using a free dermal fat graft after breast cancer surgery: multi-institutional joint research of short-term outcomes in 262 Japanese patients.

Kijima Y, Koriyama C, Fujii T, Hirokaga K, Ishigure K, Kaneko T, Kayano S, Miyamoto S, Sagara Y, Sakurai T, Sakurai T, Sotome K, Ueo H, Wakita K, Watatani M.

Gland Surg. 2015 Apr;4(2):179-94. doi: 10.3978/j.issn.2227-684X.2015.01.06. Erratum in: Gland Surg. 2017 Dec;6(6):756-757.

12.

Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.

Ueo H, Sugimachi K, Gorges TM, Bartkowiak K, Yokobori T, Müller V, Shinden Y, Ueda M, Ueo H, Mori M, Kuwano H, Maehara Y, Ohno S, Pantel K, Mimori K.

Br J Cancer. 2015 Apr 28;112(9):1519-26. doi: 10.1038/bjc.2015.132. Epub 2015 Apr 16.

13.

Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.

Sugimachi K, Matsumura T, Hirata H, Uchi R, Ueda M, Ueo H, Shinden Y, Iguchi T, Eguchi H, Shirabe K, Ochiya T, Maehara Y, Mimori K.

Br J Cancer. 2015 Feb 3;112(3):532-8. doi: 10.1038/bjc.2014.621. Epub 2015 Jan 13.

14.

F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner.

Yumimoto K, Akiyoshi S, Ueo H, Sagara Y, Onoyama I, Ueo H, Ohno S, Mori M, Mimori K, Nakayama KI.

J Clin Invest. 2015 Feb;125(2):621-35. doi: 10.1172/JCI78782. Epub 2015 Jan 2.

15.

Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.

Shinden Y, Akiyoshi S, Ueo H, Nambara S, Saito T, Komatsu H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Iguchi T, Eguchi H, Sugimachi K, Kijima Y, Ueo H, Natsugoe S, Mimori K.

Anticancer Res. 2015 Jan;35(1):123-7.

PMID:
25550542
16.

Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.

Matsumura T, Sugimachi K, Takahashi Y, Uchi R, Sawada G, Ueda M, Hirata H, Sakimura S, Ueo H, Takano Y, Kurashige J, Shinden Y, Eguchi H, Sudo T, Yamamoto H, Doki Y, Mori M, Mimori K.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S743-9. doi: 10.1245/s10434-014-3889-x. Epub 2014 Jul 17.

PMID:
25029990
17.

Loss of CDCP1 expression promotes invasiveness and poor prognosis in esophageal squamous cell carcinoma.

Sawada G, Takahashi Y, Niida A, Shimamura T, Kurashige J, Matsumura T, Ueo H, Uchi R, Takano Y, Ueda M, Hirata H, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Miyano S, Doki Y, Mori M, Mimori K.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S640-7. doi: 10.1245/s10434-014-3740-4. Epub 2014 May 22.

PMID:
24849519
18.

[Identification of genes that predict lymph node metastasis in colorectal cancer cases].

Ueo H, Takano Y, Matsumura T, Kurashige J, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Saeki H, Oki E, Morita M, Ikeda T, Maehara Y, Mimori K.

Fukuoka Igaku Zasshi. 2013 Dec;104(12):559-63. Japanese.

PMID:
24693684
19.

Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.

Sugimachi K, Yokobori T, Iinuma H, Ueda M, Ueo H, Shinden Y, Eguchi H, Sudo T, Suzuki A, Maehara Y, Mori M, Mimori K.

Ann Surg Oncol. 2014 Oct;21(11):3680-90. doi: 10.1245/s10434-013-3366-y. Epub 2013 Nov 12.

PMID:
24217791
20.

Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers.

Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Br J Cancer. 2014 Jan 7;110(1):164-71. doi: 10.1038/bjc.2013.698. Epub 2013 Nov 5.

21.

Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer.

Mima K, Fukagawa T, Kurashige J, Takano Y, Uchi R, Ueo H, Matsumura T, Ishibashi M, Sawada G, Takahashi Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Watanabe M, Ishii H, Mori M, Baba H, Sasako M, Mimori K.

Oncol Lett. 2013 Aug;6(2):387-392. Epub 2013 Jun 12.

22.

Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.

Takahashi Y, Iwaya T, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18.

PMID:
24046120
23.

Loss of COP1 expression determines poor prognosisin patients with gastric cancer.

Sawada G, Ueo H, Matsumura T, Uchi R, Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Oncol Rep. 2013 Oct;30(4):1971-5. doi: 10.3892/or.2013.2664. Epub 2013 Aug 8.

PMID:
23933908
24.

Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.

Takahashi Y, Sawada G, Sato T, Kurashige J, Mima K, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Tanaka J, Kudo SE, Doki Y, Mori M, Mimori K.

Oncol Rep. 2013 Sep;30(3):1488-96. doi: 10.3892/or.2013.2602. Epub 2013 Jul 8.

PMID:
23835740
25.

CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer.

Sawada G, Ueo H, Matsumura T, Uchi R, Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Oncol Rep. 2013 Sep;30(3):1137-42. doi: 10.3892/or.2013.2597. Epub 2013 Jul 8.

PMID:
23835524
26.

Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.

Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.

Br J Cancer. 2013 Jul 23;109(2):307-11. doi: 10.1038/bjc.2013.339. Epub 2013 Jun 27.

27.

Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.

Takahashi Y, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.

Anticancer Res. 2013 May;33(5):1927-34.

PMID:
23645740
28.

Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.

Ishibashi M, Kogo R, Shibata K, Ueo H, Uchi R, Matsumura T, Takano Y, Sawada G, Takahashi Y, Mima K, Kurashige J, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Suzuki A, Wakabayashi G, Mori M, Mimori K.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S537-44. doi: 10.1245/s10434-013-2958-x. Epub 2013 Mar 27.

PMID:
23532381
29.

Effects of dietary genistein on hormone-dependent rat mammary carcinogenesis induced by ethyl methanesulphonate.

Ono M, Koga T, Ueo H, Nakano S.

Nutr Cancer. 2012;64(8):1204-10. doi: 10.1080/01635581.2012.718035.

PMID:
23163849
30.

Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer.

Kosaka Y, Kataoka A, Yamaguchi H, Ueo H, Akiyoshi S, Sengoku N, Kuranami M, Ohno S, Watanabe M, Mimori K, Mori M.

Breast Cancer Res. 2012 Oct 31;14(5):R140. doi: 10.1186/bcr3345.

31.

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases.

Akiyoshi S, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K, Mori M.

Br J Cancer. 2012 Oct 9;107(8):1345-53. doi: 10.1038/bjc.2012.326. Epub 2012 Sep 6.

32.

Inflammatory pseudotumor of the liver in association with spilled gallstones 3 years after laparoscopic cholecystectomy: report of a case.

Kayashima H, Ikegami T, Ueo H, Tsubokawa N, Matsuura H, Okamoto D, Nakashima A, Okadome K.

Asian J Endosc Surg. 2011 Nov;4(4):181-4. doi: 10.1111/j.1758-5910.2011.00094.x.

PMID:
22776305
33.

The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancer.

Shibuta K, Ueo H, Furusawa H, Komaki K, Rai Y, Sagara Y, Kamada Y, Tamaki N.

Breast Cancer. 2011 Oct;18(4):292-8. doi: 10.1007/s12282-010-0209-6. Epub 2010 Jun 23.

PMID:
20571962
34.

Fatal winter dysentery with severe anemia in an adult cow.

Natsuaki S, Goto K, Nakamura K, Yamada M, Ueo H, Komori T, Shirakawa H, Uchinuno Y.

J Vet Med Sci. 2007 Sep;69(9):957-60.

35.
36.

Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.

Uwai Y, Motohashi H, Tsuji Y, Ueo H, Katsura T, Inui K.

Biochem Pharmacol. 2007 Jun 30;74(1):161-8. Epub 2007 Mar 30.

PMID:
17462604
37.

Cl- -dependent upregulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3.

Ueo H, Motohashi H, Katsura T, Inui K.

Am J Physiol Renal Physiol. 2007 Jul;293(1):F391-7. Epub 2007 Apr 11.

38.

Risk factors of abdominal surgery in patients with collagen diseases.

Nakashima H, Karimine N, Asoh T, Ueo H, Kohnoe S, Mori M.

Am Surg. 2006 Sep;72(9):843-8.

PMID:
16986398
39.

Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, Inui K.

Drug Metab Pharmacokinet. 2005 Oct;20(5):379-86.

40.

Prediction of early and late recurrence in patients with breast carcinoma.

Takeuchi H, Tsuji K, Ueo H.

Breast Cancer. 2005;12(3):161-5.

41.

Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.

Ueo H, Motohashi H, Katsura T, Inui K.

Biochem Pharmacol. 2005 Oct 1;70(7):1104-13.

PMID:
16098483
42.

Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.

Inoue H, Shibuta K, Matsuyama A, Yoshinaga K, Sadanaga N, Ueo H, Barnard GF, Mori M.

Oncol Rep. 2005 Sep;14(3):707-12.

PMID:
16077979
43.

Prediction of survival from first recurrence of breast carcinoma in Japanese women.

Takeuchi H, Ueo H, Tsuji K, Tokunaga E, Baba H, Maehara Y.

Breast. 2006 Apr;15(2):226-31. Epub 2005 Jul 7.

PMID:
16005234
44.

Surgical results of total pelvic exenteration for locally advanced colorectal adenocarcinoma.

Takeuchi H, Ueo H, Haraoka M, Maehara Y.

Hepatogastroenterology. 2005 Jan-Feb;52(61):90-3.

PMID:
15783002
45.

Clinicopathological feature and long-term prognosis of apocrine carcinoma of the breast in Japanese women.

Takeuchi H, Tsuji K, Ueo H, Kano T, Maehara Y.

Breast Cancer Res Treat. 2004 Nov;88(1):49-54.

PMID:
15538045
46.
47.

Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.

Sakurai Y, Motohashi H, Ueo H, Masuda S, Saito H, Okuda M, Mori N, Matsuura M, Doi T, Fukatsu A, Ogawa O, Inui K.

Pharm Res. 2004 Jan;21(1):61-7.

PMID:
14984259
48.

Clinicopathological study of Japanese male breast carcinoma.

Takeuchi H, Shirasaka C, Tsuji K, Ueo H.

Breast Cancer. 2003;10(3):249-53.

PMID:
12955038
49.

Prognostic score of gastric cancer determined by cDNA microarray.

Inoue H, Matsuyama A, Mimori K, Ueo H, Mori M.

Clin Cancer Res. 2002 Nov;8(11):3475-9.

50.

A single-nucleotide polymorphism of SMARCB1 in human breast cancers.

Mimori K, Inoue H, Shiraishi T, Ueo H, Mafune K, Tanaka Y, Mori M.

Genomics. 2002 Sep;80(3):254-8.

PMID:
12213194

Supplemental Content

Support Center